{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:12:04Z","timestamp":1783696324425,"version":"3.55.0"},"reference-count":180,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s11064-022-03595-z","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T17:05:55Z","timestamp":1650301555000},"page":"1830-1852","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Poly (ADP-ribose) polymerase: An Overview of Mechanistic Approaches and Therapeutic Opportunities in the Management of Stroke"],"prefix":"10.1007","volume":"47","author":[{"given":"Palak","family":"Tiwari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heena","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2979-1590","authenticated-orcid":false,"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amarjot Kaur","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,18]]},"reference":[{"issue":"1","key":"3595_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1742-4658.2008.06768.x","volume":"276","author":"F Moroni","year":"2009","unstructured":"Moroni F, Chiarugi A (2009) Post-ischemic brain damage: targeting PARP-1 within the ischemic neurovascular units as a realistic avenue to stroke treatment. FEBS J 276(1):36\u201345","journal-title":"FEBS J"},{"issue":"1","key":"3595_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-7-97","volume":"7","author":"SE Lakhan","year":"2009","unstructured":"Lakhan SE, Kirchgessner A, Hofer M (2009) Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med 7(1):1\u20131","journal-title":"J Transl Med"},{"issue":"6","key":"3595_CR3","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1056\/NEJMcp072057","volume":"357","author":"HB Van der Worp","year":"2007","unstructured":"Van der Worp HB, van Gijn J (2007) Acute ischemic stroke. N Eng J Med 357(6):572\u2013579","journal-title":"N Eng J Med"},{"issue":"4","key":"3595_CR4","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s12975-019-00762-3","volume":"11","author":"AN Simpkins","year":"2020","unstructured":"Simpkins AN, Janowski M, Oz HS et al (2020) Biomarker application for precision medicine in stroke. Transl stroke Res 11(4):615\u2013627","journal-title":"Transl stroke Res"},{"issue":"1","key":"3595_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.surg.2009.12.006","volume":"148","author":"RS Crawford","year":"2010","unstructured":"Crawford RS, Albadawi H, Atkins MD et al (2010) Postischemic poly (ADP-ribose) polymerase (PARP) inhibition reduces ischemia reperfusion injury in a hind-limb ischemia model. Surg 148(1):110\u2013118","journal-title":"Surg"},{"issue":"3","key":"3595_CR6","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000072668","volume":"69","author":"L Klaidman","year":"2003","unstructured":"Klaidman L, Morales M, Kem S, Yang J, Chang ML, Adams JD Jr (2003) Nicotinamide offers multiple protective mechanisms in stroke as a precursor for NAD+, as a PARP inhibitor and by partial restoration of mitochondrial function. Pharmacol 69(3):150\u2013157","journal-title":"Pharmacol"},{"key":"3595_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2022.03.016","author":"H Khan","year":"2022","unstructured":"Khan H, Grewal AK, Singh TG (2022) Pharmacological postconditioning by protocatechuic acid attenuates brain injury in ischemia-reperfusion (I\/R) mice model: Implications of nuclear factor erythroid-2-related factor pathway. Neuroscience. https:\/\/doi.org\/10.1016\/j.neuroscience.2022.03.016","journal-title":"Neuroscience"},{"issue":"9","key":"3595_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0166-2236(99)01401-0","volume":"22","author":"U Dirnagl","year":"1999","unstructured":"Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22(9):391\u2013397","journal-title":"Trends Neurosci"},{"issue":"2","key":"3595_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1006\/bbrc.1997.6910","volume":"236","author":"H Maruta","year":"1997","unstructured":"Maruta H, Matsumura N, Tanuma SI (1997) Role of (ADP-ribose)n catabolism in DNA repair. Biochem Biophys Res Commun 236(2):265\u2013269","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"3595_CR10","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/sj.cdd.4400872","volume":"8","author":"J Weise","year":"2001","unstructured":"Weise J, Isenmann S, B\u00e4hr M (2001) Increased expression and activation of poly (ADP-ribose) polymerase (PARP) contribute to retinal ganglion cell death following rat optic nerve transection. Cell Death Differ 8(8):801\u2013807","journal-title":"Cell Death Differ"},{"key":"3595_CR11","doi-asserted-by":"crossref","unstructured":"Morales J, Li L, Fattah FJ et al (2014) Review of poly (ADP-ribose) polymerase (PARP) mechanisms of action and rationale for targeting in cancer and other diseases. Crit Rev Eukaryot Gene Expr 24(1):15\u201328","DOI":"10.1615\/CritRevEukaryotGeneExpr.2013006875"},{"issue":"9","key":"3595_CR12","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1182\/blood.V97.9.2830","volume":"97","author":"O Ciftci","year":"2001","unstructured":"Ciftci O, Ullrich O, Schmidt CA, Diestel A, Hass R (2001) Regulation of the nuclear proteasome activity in myelomonocytic human leukemia cells after adriamycin treatment. Blood 97(9):2830\u20132838","journal-title":"Blood"},{"issue":"1","key":"3595_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2174\/157489206775246430","volume":"1","author":"V Cepeda","year":"2006","unstructured":"Cepeda V, Fuertes MA, Castilla J, Alonso C, Quevedo C, Soto M, P\u00e9rez JM (2006) Poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors in cancer chemotherapy. Recent Pat Anti-cancer Drug Discov 1(1):39\u201353","journal-title":"Recent Pat Anti-cancer Drug Discov"},{"issue":"3","key":"3595_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2174\/1570161054368625","volume":"3","author":"L Vir\u00e1g","year":"2005","unstructured":"Vir\u00e1g L (2005) Structure and function of poly (ADP-ribose) polymerase-1: role in oxidative stress-related pathologies. Curr Vasc Pharmacol 3(3):209\u2013214","journal-title":"Curr Vasc Pharmacol"},{"issue":"6","key":"3595_CR15","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1097\/TP.0000000000000305","volume":"98","author":"G Hatachi","year":"2014","unstructured":"Hatachi G, Tsuchiya T, Miyazaki T et al (2014) The poly (adenosine diphosphate-ribose) polymerase inhibitor PJ34 reduces pulmonary ischemia-reperfusion injury in rats. Transplantation 98(6):618","journal-title":"Transplantation"},{"issue":"3","key":"3595_CR16","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.3892\/mmr.2014.2977","volume":"11","author":"J Wang","year":"2015","unstructured":"Wang J, Hao L, Wang Y et al (2015) Inhibition of poly (ADP-ribose) polymerase and inducible nitric oxide synthase protects against ischemic myocardial damage by reduction of apoptosis. Mol Med Rep 11(3):1768\u20131776","journal-title":"Mol Med Rep"},{"issue":"1","key":"3595_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40164-019-0154-9","volume":"8","author":"M Yi","year":"2019","unstructured":"Yi M, Dong B, Qin S, Chu Q, Wu K, Luo S (2019) Advances and perspectives of PARP inhibitors. Exp Hematol Oncol 8(1):1\u20132","journal-title":"Exp Hematol Oncol"},{"issue":"5","key":"3595_CR18","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nrd1718","volume":"4","author":"P Jagtap","year":"2005","unstructured":"Jagtap P, Szab\u00f3 C (2005) Poly (ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov 4(5):421\u2013440","journal-title":"Nat Rev Drug Discov"},{"key":"3595_CR19","doi-asserted-by":"crossref","unstructured":"Nguewa PA, Fuertes MA, Valladares B, Alonso C, P\u00e9rez JM (2005) Poly (ADP-ribose) polymerases: homology, structural domains and functions. Novel therapeutical applications. Prog Biophys Mol Boil 88(1):143\u2013172","DOI":"10.1016\/j.pbiomolbio.2004.01.001"},{"issue":"3","key":"3595_CR20","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1124\/pr.54.3.375","volume":"54","author":"L Vir\u00e1g","year":"2002","unstructured":"Vir\u00e1g L, Szab\u00f3 C (2002) The therapeutic potential of poly (ADP-ribose) polymerase inhibitors. Pharmacol Rev 54(3):375\u2013429","journal-title":"Pharmacol Rev"},{"key":"3595_CR21","doi-asserted-by":"crossref","unstructured":"Khan H, Sharma K, Kumar A, Kaur A, Singh TG (2022) Therapeutic implications of cyclooxygenase (COX) inhibitors in ischemic injury. Inflamm Res 71(3):277\u2013292","DOI":"10.1007\/s00011-022-01546-6"},{"issue":"1","key":"3595_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1042\/bj2880255","volume":"288","author":"S Hauschildt","year":"1992","unstructured":"Hauschildt S, Scheipers P, Bessler WG, M\u00fclsch A (1992) Induction of nitric oxide synthase in L929 cells by tumour-necrosis factor \u03b1 is prevented by inhibitors of poly (ADP-ribose) polymerase. Biochem J 288(1):255\u2013260","journal-title":"Biochem J"},{"issue":"36","key":"3595_CR23","doi-asserted-by":"publisher","first-page":"11622","DOI":"10.1021\/bi953010z","volume":"35","author":"CM Simbulan-Rosenthal","year":"1996","unstructured":"Simbulan-Rosenthal CM, Rosenthal DS, Hilz H et al (1996) The expression of poly (ADP-ribose) polymerase during differentiation-linked DNA replication reveals that it is a component of the multiprotein DNA replication complex. Biochemistry 35(36):11622\u201311633","journal-title":"Biochemistry"},{"issue":"2","key":"3595_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1006\/phrs.2001.0935","volume":"45","author":"L Tentori","year":"2002","unstructured":"Tentori L, Portarena I, Graziani G (2002) Potential clinical applications of poly (ADP-ribose) polymerase (PARP) inhibitors. Pharmacol Res 45(2):73\u201385","journal-title":"Pharmacol Res"},{"issue":"8","key":"3595_CR25","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1242\/jcs.00341","volume":"116","author":"A Augustin","year":"2003","unstructured":"Augustin A, Spenlehauer C, Dumond H et al (2003) PARP-3 localizes preferentially to the daughter centriole and interferes with the G1\/S cell cycle progression. J Cell Sci 116(8):1551\u20131562","journal-title":"J Cell Sci"},{"issue":"5","key":"3595_CR26","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1083\/jcb.146.5.917","volume":"146","author":"VA Kickhoefer","year":"1999","unstructured":"Kickhoefer VA, Siva AC, Kedersha NL et al (1999) The 193-kD vault protein, VPARP, is a novel poly (ADP-ribose) polymerase. J Cell Biol 146(5):917\u2013928","journal-title":"J Cell Biol"},{"key":"3595_CR27","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/bies.20085","volume":"26","author":"JC Am\u00e9","year":"2004","unstructured":"Am\u00e9 JC, Spenlehauer C, de Murcia G (2004) The PARP superfamily. BioEssays 26:882\u2013893","journal-title":"BioEssays"},{"issue":"21","key":"3595_CR28","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1242\/jcs.112.21.3649","volume":"112","author":"S Smith","year":"1999","unstructured":"Smith S, de Lange T (1999) Cell cycle dependent localization of the telomeric PARP, tankyrase, to nuclear pore complexes and centrosomes. J Cell Sci 112(21):3649\u20133656","journal-title":"J Cell Sci"},{"issue":"25","key":"3595_CR29","doi-asserted-by":"publisher","first-page":"17860","DOI":"10.1074\/jbc.274.25.17860","volume":"274","author":"JC Am\u00e9","year":"1999","unstructured":"Am\u00e9 JC, Rolli V, Schreiber V et al (1999) PARP-2, A novel mammalian DNA damage-dependent poly (ADP-ribose) polymerase. J Biol Chem 274(25):17860\u201317868","journal-title":"J Biol Chem"},{"issue":"1","key":"3595_CR30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.phrs.2005.02.016","volume":"52","author":"S Cuzzocrea","year":"2005","unstructured":"Cuzzocrea S (2005) Shock, inflammation and PARP. Pharmacol Res 52(1):72\u201382","journal-title":"Pharmacol Res"},{"issue":"9","key":"3595_CR31","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1007\/s10620-014-3129-z","volume":"59","author":"SH Park","year":"2014","unstructured":"Park SH, Loftus EV, Yang SK (2014) Appendiceal skip inflammation and ulcerative colitis. Dig Dis Sci 59(9):2050\u20132057","journal-title":"Dig Dis Sci"},{"issue":"5\u20136","key":"3595_CR32","first-page":"273","volume":"57","author":"K Geboes","year":"1994","unstructured":"Geboes K (1994) From inflammation to lesion. Acta Gastroenterol Belg 57(5\u20136):273\u2013284","journal-title":"Acta Gastroenterol Belg"},{"key":"3595_CR33","doi-asserted-by":"crossref","unstructured":"Khan H, Gupta A, Singh TG, Kaur A (2021) Mechanistic insight on the role of leukotriene receptors in ischemic\u2013reperfusion injury. Pharmacol Rep 73(5):1240\u20131254","DOI":"10.1007\/s43440-021-00258-8"},{"issue":"12","key":"3595_CR34","doi-asserted-by":"publisher","first-page":"4819","DOI":"10.1182\/blood.V92.12.4819","volume":"92","author":"GE Rainger","year":"1998","unstructured":"Rainger GE, Rowley AF, Nash GB (1998) Adhesion-dependent release of elastase from human neutrophils in a novel, flow-based model: specificity of different chemotactic agents. Blood 92(12):4819\u20134827","journal-title":"Blood"},{"issue":"6917","key":"3595_CR35","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/nature01320","volume":"420","author":"C Nathan","year":"2002","unstructured":"Nathan C (2002) Points of control in inflammation. Nature 420(6917):846\u2013852","journal-title":"Nature"},{"issue":"12","key":"3595_CR36","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1093\/carcin\/9.12.2297","volume":"9","author":"E Shaeter","year":"1988","unstructured":"Shaeter E, Beecham EJ, Covey JM, Kohn K, Potter M (1988) Activated neutrophils induce prolonged DNA damage in neighbouring cells. Carcinogenesis 9(12):2297\u20132304","journal-title":"Carcinogenesis"},{"issue":"2","key":"3595_CR37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/art.1780360204","volume":"36","author":"BN Cronstein","year":"1993","unstructured":"Cronstein BN, Weissmann G (1993) The adhesion molecules of inflammation. Arthritis Rheum 36(2):147\u2013157","journal-title":"Arthritis Rheum"},{"issue":"2","key":"3595_CR38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.canlet.2004.07.013","volume":"215","author":"T Dorai","year":"2004","unstructured":"Dorai T, Aggarwal BB (2004) Role of chemopreventive agents in cancer therapy. Cancer Lett 215(2):129\u2013140","journal-title":"Cancer Lett"},{"issue":"9","key":"3595_CR39","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1007\/s00018-002-8527-2","volume":"59","author":"PO Hassa","year":"2002","unstructured":"Hassa PO, Hottiger MO (2002) The functional role of poly (ADP-ribose) polymerase 1 as novel coactivator of NF-\u03baB in inflammatory disorders. Cell Mol Life Sci CMLS 59(9):1534\u20131553","journal-title":"Cell Mol Life Sci CMLS"},{"key":"3595_CR40","first-page":"2019","volume":"31","author":"JN Zhang","year":"2019","unstructured":"Zhang JN, Ma Y, Wei XY et al (2019) Remifentanil protects against lipopolysaccharide-induced inflammation through PARP-1\/NF-\u03baB signaling PATHWAY. Mediators Inflamm 31:2019","journal-title":"Mediators Inflamm"},{"issue":"5","key":"3595_CR41","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s00726-011-0885-3","volume":"42","author":"M Sun","year":"2012","unstructured":"Sun M, Zhao Y, Gu Y, Xu C (2012) Anti-inflammatory mechanism of taurine against ischemic stroke is related to down-regulation of PARP and NF-\u03baB. Amino Acids 42(5):1735\u20131747","journal-title":"Amino Acids"},{"issue":"1","key":"3595_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/cells9010041","volume":"9","author":"S Pazzaglia","year":"2020","unstructured":"Pazzaglia S, Pioli C (2020) Multifaceted role of PARP-1 in DNA repair and inflammation: pathological and therapeutic implications in cancer and non-cancer diseases. Cells 9(1):41","journal-title":"Cells"},{"key":"3595_CR43","doi-asserted-by":"crossref","unstructured":"Hans CP, Feng Y, Naura AS et al (2009) Protective effects of PARP-1 knockout on dyslipidemia-induced autonomic and vascular dysfunction in ApoE\u2212\/\u2212 mice: effects on eNOS and oxidative stress. PLoS ONE 4(10):e7430","DOI":"10.1371\/journal.pone.0007430"},{"key":"3595_CR44","doi-asserted-by":"crossref","unstructured":"Ahmad A, de Camargo Vieira J, de Mello AH et al (2019) The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity for repurposing a clinically used oncological drug for the experimental therapy of sepsis. Pharmacol Res 145:104263","DOI":"10.1016\/j.phrs.2019.104263"},{"issue":"11","key":"3595_CR45","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1111\/jphp.13336","volume":"72","author":"H Khan","year":"2020","unstructured":"Khan H, Kashyap A, Kaur A, Singh TG (2020) Pharmacological postconditioning: a molecular aspect in ischemic injury. J Pharm Pharmacol 72(11):1513\u20131527","journal-title":"J Pharm Pharmacol"},{"key":"3595_CR46","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1046\/j.1365-2567.1998.00534.x","volume":"94","author":"L Virag","year":"1998","unstructured":"Virag L, Scott GS, Cuzzocrea S, Marmer D, Salzman AL, Szabo C (1998) Peroxynitrite-induced thymocyte apoptosis: the role of caspases and poly (ADP-ribose) synthetase (PARS) activation. Immunology 94:345\u2013355","journal-title":"Immunology"},{"issue":"3","key":"3595_CR47","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/1071576021000055262","volume":"37","author":"C Fiorillo","year":"2003","unstructured":"Fiorillo C, Ponziani V, Giannini L et al (2003) Beneficial effects of poly (ADP-ribose) polymerase inhibition against the reperfusion injury in heart transplantation. Free Radic Res 37(3):331\u2013339","journal-title":"Free Radic Res"},{"issue":"11","key":"3595_CR48","first-page":"1279","volume":"65","author":"VA Tronov","year":"2000","unstructured":"Tronov VA, Konstantinov EM (2000) Hydrogen peroxide-induced DNA repair and death of resting human blood lymphocytes. Biochem Biokhim 65(11):1279\u20131286","journal-title":"Biochem Biokhim"},{"issue":"5","key":"3595_CR49","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s11064-021-03257-6","volume":"46","author":"S Thapliyal","year":"2021","unstructured":"Thapliyal S, Singh T, Handu S, Bisht M, Kumari P, Arya P, Srivastava P, Gandham R (2021) A review on potential footprints of ferulic acid for treatment of neurological disorders. Neurochem Res 46(5):1043\u20131057","journal-title":"Neurochem Res"},{"key":"3595_CR50","doi-asserted-by":"crossref","unstructured":"Keuss MJ, Hjerpe R, Hsia O et al (2019) Unanchored tri\u2010NEDD8 inhibits PARP\u20101 to protect from oxidative stress\u2010induced cell death. EMBO J 38(6):e100024","DOI":"10.15252\/embj.2018100024"},{"issue":"9","key":"3595_CR51","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/bies.1115","volume":"23","author":"A B\u00fcrkle","year":"2001","unstructured":"B\u00fcrkle A (2001) Physiology and pathophysiology of poly (ADP-ribosyl) ation. BioEssays 23(9):795\u2013806","journal-title":"BioEssays"},{"issue":"11","key":"3595_CR52","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1139\/cjpp-2019-0188","volume":"97","author":"AK Grewal","year":"2019","unstructured":"Grewal AK, Singh N, Singh TG (2019) Effects of resveratrol postconditioning on cerebral ischemia in mice: role of the sirtuin-1 pathway. Can J Physiol Pharmacol 97(11):1094\u20131101","journal-title":"Can J Physiol Pharmacol"},{"key":"3595_CR53","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1091\/mbc.01-05-0272","volume":"13","author":"M Los","year":"2002","unstructured":"Los M, Mozoluk M, Ferrari D, Stepczynska A et al (2002) Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. Mol Biol Cell 13:978\u2013988","journal-title":"Mol Biol Cell"},{"issue":"1195","key":"3595_CR54","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.brainres.2007.12.024","volume":"21","author":"E Yap","year":"2008","unstructured":"Yap E, Tan WL, Ng I, Ng YK (2008) Combinatorial-approached neuroprotection using pan-caspase inhibitor and poly (ADP-ribose) polymerase (PARP) inhibitor following experimental stroke in rats; is there additional benefit? Brain Res 21(1195):130\u2013138","journal-title":"Brain Res"},{"issue":"1","key":"3595_CR55","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1023\/A:1006962716377","volume":"199","author":"AI Scovassi","year":"1999","unstructured":"Scovassi AI, Poirier GG (1999) Poly (ADP-ribosylation) and apoptosis. Mol Cell Biochem 199(1):125\u2013137","journal-title":"Mol Cell Biochem"},{"issue":"37","key":"3595_CR56","doi-asserted-by":"publisher","first-page":"34217","DOI":"10.1074\/jbc.M203941200","volume":"277","author":"A Benchoua","year":"2002","unstructured":"Benchoua A, Couriaud C, Gue\u00e1gan C et al (2002) Active caspase-8 translocates into the nucleus of apoptotic cells to inactivate poly (ADP-ribose) polymerase-2. J Biol Chem 277(37):34217\u201334222","journal-title":"J Biol Chem"},{"issue":"3","key":"3595_CR57","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/0304-4165(94)90084-1","volume":"1201","author":"J Hoshino","year":"1994","unstructured":"Hoshino J, Koeppel C, Westh\u00e4user E (1994) 3-Aminobenzamide enhances dexamethasone-mediated mouse thymocyte depletion in vivo: implication for a role of poly ADP-ribosylation in the negative selection of immature thymocytes. Biochim Biophys Acta Gen Subj 1201(3):516\u2013522","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"3","key":"3595_CR58","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/0006-2952(93)90525-2","volume":"46","author":"K Yamamoto","year":"1993","unstructured":"Yamamoto K, Tsukidate K, John FL (1993) Differing effects of the inhibition of poly (ADP-ribose) polymerase on the course of oxidative cell injury in hepatocytes and fibroblasts. Biochem Pharmacol 46(3):483\u2013491","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"3595_CR59","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/jcb.240480403","volume":"48","author":"SC Wright","year":"1992","unstructured":"Wright SC, Kumar P, Tam AW, Shen N, Varma M, Larrick JW (1992) Apoptosis and DNA fragmentation precede TNF-induced cytolysis in U937 cells. J Cell Biochem 48(4):344\u2013355","journal-title":"J Cell Biochem"},{"issue":"2","key":"3595_CR60","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1006\/bbrc.1996.0263","volume":"219","author":"ML Kuo","year":"1996","unstructured":"Kuo ML, Chau YP, Wang JH, Shiah SG (1996) Inhibitors of poly (ADP-ribose) polymerase block nitric oxide-induced apoptosis but not differentiation in human leukemia HL-60 cells. Biochem Biophys Res Commun 219(2):502\u2013508","journal-title":"Biochem Biophys Res Commun"},{"key":"3595_CR61","doi-asserted-by":"crossref","unstructured":"Bhatia S, Rawal R, Sharma P, Singh T, Singh M, Singh V (2021) Mitochondrial dysfunction in Alzheimer's disease: opportunities for drug development. Curr Neuropharmacol 20(4):675\u2013692","DOI":"10.2174\/1570159X19666210517114016"},{"issue":"1","key":"3595_CR62","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s12975-013-0283-0","volume":"5","author":"P Baxter","year":"2014","unstructured":"Baxter P, Chen Y, Xu Y, Swanson RA (2014) Mitochondrial dysfunction induced by nuclear poly (ADP-ribose) polymerase-1: a treatable cause of cell death in stroke. Transl Stroke Res 5(1):136\u2013144","journal-title":"Transl Stroke Res"},{"issue":"18","key":"3595_CR63","doi-asserted-by":"publisher","first-page":"18895","DOI":"10.1074\/jbc.M313329200","volume":"279","author":"CC Alano","year":"2004","unstructured":"Alano CC, Ying W, Swanson RA (2004) Poly (ADP-ribose) polymerase-1-mediated cell death in astrocytes requires NAD+ depletion and mitochondrial permeability transition. J Biol Chem 279(18):18895\u201318902","journal-title":"J Biol Chem"},{"issue":"13","key":"3595_CR64","doi-asserted-by":"publisher","first-page":"8788","DOI":"10.1074\/jbc.M508135200","volume":"281","author":"Y Xu","year":"2006","unstructured":"Xu Y, Huang S, Liu ZG, Han J (2006) Poly (ADP-ribose) polymerase-1 signaling to mitochondria in necrotic cell death requires RIP1\/TRAF2-mediated JNK1 activation. J Biol Chem 281(13):8788\u20138795","journal-title":"J Biol Chem"},{"issue":"1","key":"3595_CR65","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.freeradbiomed.2005.03.021","volume":"39","author":"SJ van Wijk","year":"2005","unstructured":"van Wijk SJ, Hageman GJ (2005) Poly (ADP-ribose) polymerase-1 mediated caspase-independent cell death after ischemia\/reperfusion. Free Radic Biol Med 39(1):81\u201390","journal-title":"Free Radic Biol Med"},{"key":"3595_CR66","doi-asserted-by":"crossref","unstructured":"Kadam A, Jubin T, Roychowdhury R, Begum R (2020) Role of PARP-1 in mitochondrial homeostasis. Biochim Biophys Acta (BBA) Gen Subj 1864(10):129669","DOI":"10.1016\/j.bbagen.2020.129669"},{"key":"3595_CR67","doi-asserted-by":"crossref","unstructured":"Singh T, Batabyal T, Kapur J (2022) Neuronal circuits sustaining neocortical-injury-induced status epilepticus. Neurobiol Dis 165:105633","DOI":"10.1016\/j.nbd.2022.105633"},{"issue":"21","key":"3595_CR68","doi-asserted-by":"publisher","first-page":"8005","DOI":"10.1523\/JNEUROSCI.20-21-08005.2000","volume":"20","author":"AS Mandir","year":"2000","unstructured":"Mandir AS, Poitras MF, Berliner AR et al (2000) NMDA but not non-NMDA excitotoxicity is mediated by poly (ADP-ribose) polymerase. J Neurosci 20(21):8005\u20138011","journal-title":"J Neurosci"},{"issue":"1","key":"3595_CR69","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.expneurol.2003.07.003","volume":"184","author":"KL Gilliams-Francis","year":"2003","unstructured":"Gilliams-Francis KL, Quaye AA, Naegele JR (2003) PARP cleavage, DNA fragmentation, and pyknosis during excitotoxin-induced neuronal death. Exp Neurol 184(1):359\u2013372","journal-title":"Exp Neurol"},{"issue":"1","key":"3595_CR70","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/jnr.490390106","volume":"39","author":"C Cosi","year":"1994","unstructured":"Cosi C, Suzuki H, Milani D et al (1994) Poly (ADP-ribose) polymerase: early involvement in glutamate-induced neurotoxicity in cultured cerebellar granule cells. J Neurosci Res 39(1):38\u201346","journal-title":"J Neurosci Res"},{"issue":"2\u20133","key":"3595_CR71","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0378-4274(02)00429-0","volume":"139","author":"E Meli","year":"2003","unstructured":"Meli E, Pangallo M, Baronti R et al (2003) Poly (ADP-ribose) polymerase as a key player in excitotoxicity and post-ischemic brain damage. Toxicol Lett 139(2\u20133):153\u2013162","journal-title":"Toxicol Lett"},{"issue":"2","key":"3595_CR72","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2174\/1568007053544138","volume":"4","author":"K Komj\u00e1ti","year":"2005","unstructured":"Komj\u00e1ti K, Besson VC, Szabo C (2005) Poly (adp-ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma. Curr Drug Targets CNS Neurol Disord 4(2):179\u2013194","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"issue":"5","key":"3595_CR73","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.brainresbull.2003.11.001","volume":"62","author":"DG Kabra","year":"2004","unstructured":"Kabra DG, Thiyagarajan M, Kaul CL, Sharma SS (2004) Neuroprotective effect of 4-amino-1,8-napthalimide, a poly (ADP ribose) polymerase inhibitor in middle cerebral artery occlusion-induced focal cerebral ischemia in rat. Brain Res Bull 62(5):425\u2013433","journal-title":"Brain Res Bull"},{"issue":"2","key":"3595_CR74","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0021-9150(99)00284-1","volume":"148","author":"N Kato","year":"2000","unstructured":"Kato N, Morita H, Sugiyama T et al (2000) Evaluation of the poly (ADP-ribose) polymerase gene in human stroke. Atherosclerosis 148(2):345\u2013352","journal-title":"Atherosclerosis"},{"issue":"3","key":"3595_CR75","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/00001756-199312000-00015","volume":"5","author":"RA Wallis","year":"1993","unstructured":"Wallis RA, Panizzon KL, Henry D, Wasterlain CG (1993) Neuroprotection against nitric oxide injury with inhibitors of ADP-ribosylation. NeuroReport 5(3):245\u2013248","journal-title":"NeuroReport"},{"issue":"3","key":"3595_CR76","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0306-4522(97)00181-4","volume":"81","author":"U W\u00fcllner","year":"1997","unstructured":"W\u00fcllner U, Weller M, Groscurth P et al (1997) Evidence for an active type of cell death with ultrastructural features distinct from apoptosis: the effects of 3-acetylpyridine neurotoxicity. Neuroscience 81(3):721\u2013734","journal-title":"Neuroscience"},{"issue":"2","key":"3595_CR77","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1046\/j.1471-4159.1998.70020501.x","volume":"70","author":"MR Cookson","year":"1998","unstructured":"Cookson MR, Ince PG, Shaw PJ (1998) Peroxynitrite and hydrogen peroxide induced cell death in the NSC34 neuroblastoma \u00d7 spinal cord cell line: role of poly (ADP-ribose) polymerase. J Neurochem 70(2):501\u2013508","journal-title":"J Neurochem"},{"issue":"12","key":"3595_CR78","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1097\/00004647-199812000-00009","volume":"18","author":"RC Tasker","year":"1998","unstructured":"Tasker RC, Sahota SK, Cotter FE, Williams SR (1998) Early postischemic dantrolene-induced amelioration of poly (ADP-ribose) polymerase-related bioenergetic failure in neonatal rat brain slices. J Cereb Blood Flow Metab 18(12):1346\u20131356","journal-title":"J Cereb Blood Flow Metab"},{"issue":"7","key":"3595_CR79","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1097\/00001756-200005150-00007","volume":"11","author":"W Ying","year":"2000","unstructured":"Ying W, Swanson RA (2000) The poly (ADP-ribose) glycohydrolase inhibitor gallotannin blocks oxidative astrocyte death. NeuroReport 11(7):1385\u20131388","journal-title":"NeuroReport"},{"issue":"18","key":"3595_CR80","doi-asserted-by":"publisher","first-page":"6920","DOI":"10.1523\/JNEUROSCI.20-18-06920.2000","volume":"20","author":"II Kruman","year":"2000","unstructured":"Kruman II, Culmsee C, Chan SL et al (2000) Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 20(18):6920\u20136926","journal-title":"J Neurosci"},{"issue":"7","key":"3595_CR81","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/S0028-3908(99)00197-5","volume":"39","author":"M Oka","year":"2000","unstructured":"Oka M, Hirouchi M, Itoh Y, Ukai Y (2000) Involvement of peroxynitrite and hydroxyradical generated from nitric oxide in hypoxia\/reoxygenation injury in rat cerebrocortical slices. Neuropharmacology 39(7):1319\u20131330","journal-title":"Neuropharmacology"},{"issue":"3","key":"3595_CR82","first-page":"255","volume":"7","author":"GE Abdelkarim","year":"2001","unstructured":"Abdelkarim GE, Gertz K, Harms C et al (2001) Protective effects of PJ34, a novel, potent inhibitor of poly (ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke. Int J Mol Med 7(3):255\u2013260","journal-title":"Int J Mol Med"},{"issue":"21","key":"3595_CR83","doi-asserted-by":"publisher","first-page":"12227","DOI":"10.1073\/pnas.211202598","volume":"98","author":"W Ying","year":"2001","unstructured":"Ying W, Sevigny MB, Chen Y, Swanson RA (2001) Poly (ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death. Proc Natl Acad Sci USA 98(21):12227\u201312232","journal-title":"Proc Natl Acad Sci USA"},{"key":"3595_CR84","doi-asserted-by":"crossref","unstructured":"Ullrich O, Diestel A, Ey\u00fcpoglu IY, Nitsch R (2001) Regulation of microglial expression of integrins by poly (ADP-ribose) polymerase-1. Nat Cell Biol 3:1035\u20131042","DOI":"10.1038\/ncb1201-1035"},{"key":"3595_CR85","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/sj.cdd.4400884","volume":"8","author":"F Moroni","year":"2001","unstructured":"Moroni F, Meli E, Peruginelli F et al (2001) Poly (ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia. Cell Death Differ 8:921\u2013932","journal-title":"Cell Death Differ"},{"issue":"7\u20138","key":"3595_CR86","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1080\/1029842021000045480","volume":"4","author":"M Sonee","year":"2002","unstructured":"Sonee M, Martens JR, Mukherjee SK (2002) Nicotinamide protects HCN2 cells from the free radical generating toxin, tertiary-butylhydroperoxide (t-BuOOH). Neurotoxicity Res 4(7\u20138):595\u2013599","journal-title":"Neurotoxicity Res"},{"issue":"3","key":"3595_CR87","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0161-813X(03)00019-6","volume":"24","author":"M Sonee","year":"2003","unstructured":"Sonee M, Martens JR, Evers MR, Mukherjee SK (2003) The effect of tertiary butylhydroperoxide and nicotinamide on human cortical neurons. Neurotoxicol 24(3):443\u2013448","journal-title":"Neurotoxicol"},{"issue":"1","key":"3595_CR88","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.brainres.2003.10.051","volume":"997","author":"F Huang","year":"2004","unstructured":"Huang F, Vemuri MC, Schneider JS (2004) Modulation of ATP levels alters the mode of hydrogen peroxide-induced cell death in primary cortical cultures: effects of putative neuroprotective agents. Brain Res 997(1):79\u201388","journal-title":"Brain Res"},{"issue":"3","key":"3595_CR89","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0304-3959(97)00063-8","volume":"72","author":"J Mao","year":"1997","unstructured":"Mao J, Price DD, Zhu J, Lu J, Mayer DJ (1997) The inhibition of nitric oxide-activated poly (ADP-ribose) synthetase attenuates transsynaptic alteration of spinal cord dorsal horn neurons and neuropathic pain in the rat. Pain 72(3):355\u2013366","journal-title":"Pain"},{"issue":"9","key":"3595_CR90","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1097\/00004647-199809000-00008","volume":"18","author":"T Tokime","year":"1998","unstructured":"Tokime T, Nozaki K, Sugino T, Kikuchi H, Hashimoto N, Ueda K (1998) Enhanced poly (ADP-ribosyl) ation after focal ischemia in rat brain. J Cereb Blood Flow Metab 18(9):991\u2013997","journal-title":"J Cereb Blood Flow Metab"},{"key":"3595_CR91","doi-asserted-by":"crossref","unstructured":"Lo EH, Bosque-Hamilton P, Meng W (1998) Inhibition of poly(ADP-ribose) polymerase: reduction of ischemic injury and attenuation of N-methyl-D-aspartate-induced neurotransmitter dysregulation. Stroke 9(4):830\u2013836","DOI":"10.1161\/01.STR.29.4.830"},{"issue":"1\u20132","key":"3595_CR92","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0006-8993(99)01335-9","volume":"829","author":"K Takahashi","year":"1999","unstructured":"Takahashi K, Pieper AA, Croul SE, Zhang J, Snyder SH, Greenberg JH (1999) Post-treatment with an inhibitor of poly (ADP-ribose) polymerase attenuates cerebral damage in focal ischemia. Brain Res 829(1\u20132):46\u201354","journal-title":"Brain Res"},{"issue":"5","key":"3595_CR93","doi-asserted-by":"publisher","first-page":"R1834","DOI":"10.1152\/ajpregu.2000.279.5.R1834","volume":"279","author":"DR Martin","year":"2000","unstructured":"Martin DR, Lewington AJ, Hammerman MR, Padanilam BJ (2000) Inhibition of poly (ADP-ribose) polymerase attenuates ischemic renal injury in rats. Am J Physiol Regul Integr Comp Physiol 279(5):R1834\u2013R1840","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1\u20132","key":"3595_CR94","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0304-3940(00)00988-5","volume":"284","author":"K Plaschke","year":"2000","unstructured":"Plaschke K, Kopitz J, Weigand MA, Martin E, Bardenheuer HJ (2000) The neuroprotective effect of cerebral poly (ADP-ribose) polymerase inhibition in a rat model of global ischemia. Neurosci Lett 284(1\u20132):109\u2013112","journal-title":"Neurosci Lett"},{"issue":"2","key":"3595_CR95","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1177\/000348940111000205","volume":"110","author":"Z Ito","year":"2001","unstructured":"Ito Z, Serizawa F, Tabuchi K et al (2001) Poly (adenosine diphosphate-ribose) synthetase inhibitor 3-aminobenzamide alleviates cochlear dysfunction induced by transient ischemia. Ann Otol Rhinol Laryngol 110(2):118\u2013121","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"1","key":"3595_CR96","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1161\/01.STR.32.1.225","volume":"32","author":"M Satoh","year":"2001","unstructured":"Satoh M, Date I, Nakajima M et al (2001) Inhibition of poly (ADP-ribose) polymerase attenuates cerebral vasospasm after subarachnoid hemorrhage in rabbits. Stroke 32(1):225\u2013230","journal-title":"Stroke"},{"issue":"4","key":"3595_CR97","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S0091-3057(02)00939-5","volume":"73","author":"J Yang","year":"2002","unstructured":"Yang J, Klaidman LK, Chang ML et al (2002) Nicotinamide therapy protects against both necrosis and apoptosis in a stroke model. Pharmacol Biochem Behav 73(4):901\u2013910","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"3595_CR98","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1161\/01.STR.0000014203.65693.1E","volume":"33","author":"S Goto","year":"2002","unstructured":"Goto S, Xue R, Sugo N et al (2002) Poly (ADP-ribose) polymerase impairs early and long-term experimental stroke recovery. Stroke 33(4):1101\u20131106","journal-title":"Stroke"},{"issue":"1","key":"3595_CR99","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1179\/016164104773026624","volume":"26","author":"S Gupta","year":"2004","unstructured":"Gupta S, Kaul CL, Sharma SS (2004) Neuroprotective effect of combination of poly (ADP-ribose) polymerase inhibitor and antioxidant in middle cerebral artery occlusion induced focal ischemia in rats. Neurol Res 26(1):103\u2013107","journal-title":"Neurol Res"},{"issue":"2","key":"3595_CR100","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1124\/jpet.104.066944","volume":"310","author":"A Iwashita","year":"2004","unstructured":"Iwashita A, Tojo N, Matsuura S et al (2004) A novel and potent poly (ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3, 6-dihydro-1 (2H)-pyridinyl) propyl]-4 (3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia. J Pharmacol Exp Ther 310(2):425\u2013436","journal-title":"J Pharmacol Exp Ther"},{"key":"3595_CR101","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1001\/archsurg.140.4.344","volume":"140","author":"HT Hua","year":"2005","unstructured":"Hua HT, Albadawi H, Entabi F, Conrad M et al (2005) Polyadenosine diphosphate-ribose polymerase inhibition modulates skeletal muscle injury following ischemia reperfusion. Arch Surg 140:344\u2013351","journal-title":"Arch Surg"},{"issue":"4","key":"3595_CR102","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/jcbfm.2009.9","volume":"29","author":"TM Kauppinen","year":"2009","unstructured":"Kauppinen TM, Suh SW, Berman AE, Hamby AM, Swanson RA (2009) Inhibition of poly (ADP-ribose) polymerase suppresses inflammation and promotes recovery after ischemic injury. J Cereb Blood Flow Metab 29(4):820\u2013829","journal-title":"J Cereb Blood Flow Metab"},{"key":"3595_CR103","doi-asserted-by":"crossref","unstructured":"Kl\u00f6fers M, Kohaut J, Bendix I et al (2017) Effects of poly (ADP-ribose) polymerase-1 inhibition in a neonatal rodent model of hypoxic-ischemic injury. BioMed Res Int 2017:2924848","DOI":"10.1155\/2017\/2924848"},{"issue":"3","key":"3595_CR104","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.ajpath.2010.12.004","volume":"178","author":"X Ba","year":"2011","unstructured":"Ba X, Garg NJ (2011) Signaling mechanism of poly (ADP-ribose) polymerase-1 (PARP-1) in inflammatory diseases. Am J Pathol 178(3):946\u2013955","journal-title":"Am J Pathol"},{"issue":"2","key":"3595_CR105","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.tem.2014.11.003","volume":"26","author":"P Bai","year":"2015","unstructured":"Bai P, Nagy L, Fodor T, Liaudet L, Pacher P (2015) Poly (ADP-ribose) polymerases as modulators of mitochondrial activity. Trends Endocrinol Metab 26(2):75\u201383","journal-title":"Trends Endocrinol Metab"},{"key":"3595_CR106","doi-asserted-by":"crossref","unstructured":"Khan H, Singh A, Thapa K, Garg N, Grewal AK, Singh TG (2021) Therapeutic modulation of the phosphatidylinositol 3-kinases (PI3K) pathway in cerebral ischemic injury. Brain Res 1761:147399","DOI":"10.1016\/j.brainres.2021.147399"},{"issue":"1","key":"3595_CR107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"H Zhu","year":"2016","unstructured":"Zhu H, Zhang Y, Shi Z et al (2016) The neuroprotection of liraglutide against ischaemia-induced apoptosis through the activation of the PI3K\/AKT and MAPK pathways. Sci Rep 6(1):1\u20131","journal-title":"Sci Rep"},{"issue":"3","key":"3595_CR108","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/01.tp.0000276924.08343.78","volume":"84","author":"L Gao","year":"2007","unstructured":"Gao L, Kwan JC, Macdonald PS, Yang L, Preiss T, Hicks M (2007) Improved poststorage cardiac function by poly (ADP-ribose) polymerase inhibition: role of phosphatidylinositol 3-kinase Akt pathway. Transplantation 84(3):380\u2013386","journal-title":"Transplantation"},{"key":"3595_CR109","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.brainres.2007.12.059","volume":"1197","author":"L Li","year":"2008","unstructured":"Li L, Qu Y, Mao M, Xiong Y, Mu D (2008) The involvement of phosphoinositid 3-kinase\/Akt pathway in the activation of hypoxia-inducible factor-1\u03b1 in the developing rat brain after hypoxia\u2013ischemia. Brain Res 1197:152\u2013158","journal-title":"Brain Res"},{"issue":"6","key":"3595_CR110","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/j.1460-9568.2004.03632.x","volume":"20","author":"SH Koh","year":"2004","unstructured":"Koh SH, Park Y, Song CW et al (2004) The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signals. Eur J Neurosci 20(6):1461\u20131472","journal-title":"Eur J Neurosci"},{"issue":"4","key":"3595_CR111","first-page":"3547","volume":"18","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Yao L, Yang J, Wang Z, Du G (2018) PI3K\/Akt and HIF-1 signaling pathway in hypoxia-ischemia. Mol Med Rep 18(4):3547\u20133554","journal-title":"Mol Med Rep"},{"issue":"42","key":"3595_CR112","doi-asserted-by":"publisher","first-page":"35767","DOI":"10.1074\/jbc.M507075200","volume":"280","author":"A Tapodi","year":"2005","unstructured":"Tapodi A, Debreceni B, Hanto K et al (2005) Pivotal role of Akt activation in mitochondrial protection and cell survival by poly (ADP-ribose) polymerase-1 inhibition in oxidative stress. J Biol Chem 280(42):35767\u201335775","journal-title":"J Biol Chem"},{"issue":"12","key":"3595_CR113","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1111\/epi.16715","volume":"61","author":"T Singh","year":"2020","unstructured":"Singh T, Joshi S, Williamson JM, Kapur J (2020) Neocortical injury\u2013induced status epilepticus. Epilepsia 61(12):2811\u20132824","journal-title":"Epilepsia"},{"key":"3595_CR114","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bcp.2018.10.005","volume":"162","author":"A Tapodi","year":"2019","unstructured":"Tapodi A, Bognar Z, Szabo C, Gallyas F, Sumegi B, Hocsak E (2019) PARP inhibition induces Akt-mediated cytoprotective effects through the formation of a mitochondria-targeted phospho-ATM-NEMO-Akt-mTOR signalosome. Biochem Pharmacol 162:98\u2013108","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"3595_CR115","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s12031-010-9461-7","volume":"43","author":"SS Prasad","year":"2011","unstructured":"Prasad SS, Russell M, Nowakowska M (2011) Neuroprotection induced in vitro by ischemic preconditioning and postconditioning: modulation of apoptosis and PI3K\u2013Akt pathways. J Mol Neurosci 43(3):428\u2013442","journal-title":"J Mol Neurosci"},{"issue":"6","key":"3595_CR116","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1159\/000491655","volume":"47","author":"X Li","year":"2018","unstructured":"Li X, Huang Q, Wang M et al (2018) Compound K inhibits autophagy-mediated apoptosis through activation of the PI3K-Akt signaling pathway thus protecting against ischemia\/reperfusion injury. Cell Physiol Biochem 47(6):2589\u20132601","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"3595_CR117","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s12640-009-9049-6","volume":"16","author":"L Mester","year":"2009","unstructured":"Mester L, Szabo A, Atlasz T et al (2009) Protection against chronic hypoperfusion-induced retinal neurodegeneration by PARP inhibition via activation of PI-3-kinase Akt pathway and suppression of JNK and p38 MAP kinases. Neurotoxicol Res 16(1):68\u201376","journal-title":"Neurotoxicol Res"},{"issue":"21","key":"3595_CR118","doi-asserted-by":"publisher","first-page":"20493","DOI":"10.1074\/jbc.M409985200","volume":"280","author":"LD McCullough","year":"2005","unstructured":"McCullough LD, Zeng Z, Li H, Landree LE, McFadden J, Ronnett GV (2005) Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke. J Biol Chem 280(21):20493\u201320502","journal-title":"J Biol Chem"},{"issue":"1","key":"3595_CR119","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11011-013-9475-2","volume":"29","author":"G Ashabi","year":"2014","unstructured":"Ashabi G, Khodagholi F, Khalaj L, Goudarzvand M, Nasiri M (2014) Activation of AMP-activated protein kinase by metformin protects against global cerebral ischemia in male rats: interference of AMPK\/PGC-1\u03b1 pathway. Metab Brain Dis 29(1):47\u201358","journal-title":"Metab Brain Dis"},{"issue":"6","key":"3595_CR120","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.mam.2013.01.007","volume":"34","author":"L Vir\u00e1g","year":"2013","unstructured":"Vir\u00e1g L, Robaszkiewicz A, Rodriguez-Vargas JM, Oliver FJ (2013) Poly (ADP-ribose) signaling in cell death. Mol Aspects Med 34(6):1153\u20131167","journal-title":"Mol Aspects Med"},{"key":"3595_CR121","doi-asserted-by":"crossref","unstructured":"Huang Q, Lou T, Wang M et al (2020) Compound K inhibits autophagy-mediated apoptosis induced by oxygen and glucose deprivation\/reperfusion via regulating AMPK-mTOR pathway in neurons. Life Sci 254:117793","DOI":"10.1016\/j.lfs.2020.117793"},{"key":"3595_CR122","doi-asserted-by":"crossref","unstructured":"Thapa K, Khan H, Sharma U, Grewal AK, Singh TG (2020) Poly (ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseases. Life Sci 267:118975","DOI":"10.1016\/j.lfs.2020.118975"},{"issue":"1","key":"3595_CR123","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.gendis.2015.12.002","volume":"3","author":"B Zhao","year":"2016","unstructured":"Zhao B, Qiang L, Joseph J, Kalyanaraman B, Viollet B, He YY (2016) Mitochondrial dysfunction activates the AMPK signaling and autophagy to promote cell survival. Genes Dis 3(1):82\u201387","journal-title":"Genes Dis"},{"key":"3595_CR124","doi-asserted-by":"crossref","unstructured":"Kalra P, Khan H, Kaur A, Singh TG (2022) Mechanistic insight on autophagy modulated molecular pathways in cerebral ischemic injury: from preclinical to clinical perspective. Neurochem Res 47(4):825\u2013843","DOI":"10.1007\/s11064-021-03500-0"},{"issue":"5","key":"3595_CR125","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1111\/j.1471-4159.2004.02547.x","volume":"90","author":"H Hagberg","year":"2004","unstructured":"Hagberg H, Wilson MA, Matsushita H et al (2004) PARP-1 gene disruption in mice preferentially protects males from perinatal brain injury. J Neurochem 90(5):1068\u20131075","journal-title":"J Neurochem"},{"issue":"4","key":"3595_CR126","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/sj.jcbfm.9600059","volume":"25","author":"LD McCullough","year":"2005","unstructured":"McCullough LD, Zeng Z, Blizzard KK, Debchoudhury I, Hurn PD (2005) Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection. J Cereb Blood Flow Metab 25(4):502\u2013512","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"3595_CR127","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1369\/jhc.2008.952044","volume":"57","author":"A Bressenot","year":"2009","unstructured":"Bressenot A, Marchal S, Bezdetnaya L, Garrier J, Guillemin F, Pl\u00e9nat F (2009) Assessment of apoptosis by immunohistochemistry to active caspase-3, active caspase-7, or cleaved PARP in monolayer cells and spheroid and subcutaneous xenografts of human carcinoma. J Histochem Cytochem 57(4):289\u2013300","journal-title":"J Histochem Cytochem"},{"issue":"33","key":"3595_CR128","doi-asserted-by":"publisher","first-page":"22932","DOI":"10.1074\/jbc.274.33.22932","volume":"274","author":"AH Boulares","year":"1999","unstructured":"Boulares AH, Yakovlev AG, Ivanova V et al (1999) Role of poly (ADP-ribose) polymerase (PARP) cleavage in apoptosis: caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J Biol Chem 274(33):22932\u201322940","journal-title":"J Biol Chem"},{"issue":"4","key":"3595_CR129","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00401-009-0559-3","volume":"118","author":"T Sairanen","year":"2009","unstructured":"Sairanen T, Szepesi R, Karjalainen-Lindsberg ML, Saksi J, Paetau A, Lindsberg PJ (2009) Neuronal caspase-3 and PARP-1 correlate differentially with apoptosis and necrosis in ischemic human stroke. Acta Neuropathol 118(4):541\u2013552","journal-title":"Acta Neuropathol"},{"issue":"1","key":"3595_CR130","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1196\/annals.1397.060","volume":"1095","author":"M Shakibaei","year":"2007","unstructured":"Shakibaei M, John T, Seifarth C, Mobasheri AL (2007) Resveratrol inhibits IL-1\u03b2\u2013induced stimulation of caspase-3 and cleavage of PARP in human articular chondrocytes in vitro. Ann NY Acad Sci 1095(1):554\u2013563","journal-title":"Ann NY Acad Sci"},{"key":"3595_CR131","doi-asserted-by":"publisher","unstructured":"Rihal V, Khan H, Kaur A, Singh TG (2022) Vitamin D as therapeutic modulator in cerebrovascular diseases: a mechanistic perspectives. Crit Rev Food Sci Nutr. https:\/\/doi.org\/10.1080\/10408398.2022.2050349","DOI":"10.1080\/10408398.2022.2050349"},{"issue":"4","key":"3595_CR132","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/jnen\/62.4.329","volume":"62","author":"I Ferrer","year":"2003","unstructured":"Ferrer I, Planas AM (2003) Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra. J Neuropathol Exp Neurol 62(4):329\u2013339","journal-title":"J Neuropathol Exp Neurol"},{"issue":"40","key":"3595_CR133","doi-asserted-by":"publisher","first-page":"28379","DOI":"10.1074\/jbc.274.40.28379","volume":"274","author":"M Germain","year":"1999","unstructured":"Germain M, Affar EB, D\u2019Amours D, Dixit VM, Salvesen GS, Poirier GG (1999) Cleavage of automodified poly (ADP-ribose) polymerase during apoptosis: evidence for involvement of caspase-7. J Biol Chem 274(40):28379\u201328384","journal-title":"J Biol Chem"},{"key":"3595_CR134","doi-asserted-by":"crossref","unstructured":"Saklani P, Khan H, Gupta S, Kaur A, Singh TG (2022) Neuropeptides: potential neuroprotective agents in ischemic injury. Life Sci 288:120186","DOI":"10.1016\/j.lfs.2021.120186"},{"issue":"2","key":"3595_CR135","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.taap.2003.11.012","volume":"195","author":"K Prabhakaran","year":"2004","unstructured":"Prabhakaran K, Li L, Borowitz JL, Isom GE (2004) Caspase inhibition switches the mode of cell death induced by cyanide by enhancing reactive oxygen species generation and PARP-1 activation. Toxicol Appl Pharmacol 195(2):194\u2013202","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"3595_CR136","doi-asserted-by":"publisher","first-page":"598","DOI":"10.4161\/auto.7.6.15103","volume":"7","author":"N Zhang","year":"2011","unstructured":"Zhang N, Chen Y, Jiang R et al (2011) PARP and RIP 1 are required for autophagy induced by 11\u2019-deoxyverticillin A, which precedes caspase-dependent apoptosis. Autophagy 7(6):598\u2013612","journal-title":"Autophagy"},{"issue":"6","key":"3595_CR137","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/S0028-3908(02)00032-1","volume":"42","author":"J Krupinski","year":"2002","unstructured":"Krupinski J, Ferrer I, Barrachina M, Secades JJ, Mercadal J, Lozano R (2002) CDP-choline reduces pro-caspase and cleaved caspase-3 expression, nuclear DNA fragmentation, and specific PARP-cleaved products of caspase activation following middle cerebral artery occlusion in the rat. Neuropharmacology 42(6):846\u2013854","journal-title":"Neuropharmacology"},{"issue":"4","key":"3595_CR138","doi-asserted-by":"publisher","first-page":"326","DOI":"10.2174\/187153011797881184","volume":"11","author":"F Laudisi","year":"2011","unstructured":"Laudisi F, Sambucci M, Pioli C (2011) Poly (ADP-ribose) polymerase-1 (PARP-1) as immune regulator. Endocr Metab Immune Disord Drug Targets 11(4):326\u2013333","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"2","key":"3595_CR139","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12035-010-8124-6","volume":"41","author":"RP Strosznajder","year":"2010","unstructured":"Strosznajder RP, Czubowicz K, Jesko H, Strosznajder JB (2010) Poly (ADP-ribose) metabolism in brain and its role in ischemia pathology. Mol Neurobiol 41(2):187\u2013196","journal-title":"Mol Neurobiol"},{"issue":"2","key":"3595_CR140","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1161\/01.STR.0000250742.61241.79","volume":"38","author":"AM Hamby","year":"2007","unstructured":"Hamby AM, Suh SW, Kauppinen TM, Swanson RA (2007) Use of a poly (ADP-ribose) polymerase inhibitor to suppress inflammation and neuronal death after cerebral ischemia-reperfusion. Stroke 38(2):632\u2013636","journal-title":"Stroke"},{"issue":"1\u20133","key":"3595_CR141","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ejphar.2007.07.013","volume":"573","author":"L Geraets","year":"2007","unstructured":"Geraets L, Moonen HJ, Brauers K, Gottschalk RW, Wouters EF, Bast A, Hageman GJ (2007) Flavone as PARP-1 inhibitor: its effect on lipopolysaccharide induced gene-expression. Eur J Pharmacol 573(1\u20133):241\u2013248","journal-title":"Eur J Pharmacol"},{"key":"3595_CR142","doi-asserted-by":"crossref","unstructured":"Castri P, Lee YJ, Ponzio T et al (2014) Poly (ADP-ribose) polymerase-1 and its cleavage products differentially modulate cellular protection through NF-kB-dependent signaling Biochim Biophys Acta (BBA) Mol Cell Res 1843(3):640\u2013651","DOI":"10.1016\/j.bbamcr.2013.12.005"},{"key":"3595_CR143","doi-asserted-by":"crossref","unstructured":"Wang G, Huang X, Li Y, Guo K, Ning P, Zhang Y (2013) PARP-1 inhibitor, DPQ, attenuates LPS-induced acute lung injury through inhibiting NF-\u03baB-mediated inflammatory response. PLoS ONE 8(11):e79757","DOI":"10.1371\/journal.pone.0079757"},{"key":"3595_CR144","doi-asserted-by":"crossref","unstructured":"Martire S, Fuso A, Rotili D et al (2013) PARP-1 modulates amyloid beta peptide-induced neuronal damage. PLoS ONE 8(9):e72169","DOI":"10.1371\/journal.pone.0072169"},{"issue":"12","key":"3595_CR145","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1007\/s11064-008-9835-1","volume":"33","author":"V Spina-Purrello","year":"2008","unstructured":"Spina-Purrello V, Patti D, Giuffrida-Stella AM, Nicoletti VG (2008) PARP and cell death or protection in rat primary astroglial cell cultures under LPS\/IFN\u03b3 induced proinflammatory conditions. Neurochem Res 33(12):2583\u20132592","journal-title":"Neurochem Res"},{"issue":"1\u20132","key":"3595_CR146","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.tox.2005.06.023","volume":"214","author":"SH Koh","year":"2005","unstructured":"Koh SH, Chang DI, Kim HT et al (2005) Effect of 3-aminobenzamide, PARP inhibitor, on matrix metalloproteinase-9 level in plasma and brain of ischemic stroke model. Toxicology 214(1\u20132):131\u2013139","journal-title":"Toxicology"},{"key":"3595_CR147","doi-asserted-by":"crossref","unstructured":"Gao Y, Bai L, Zhou W et al (2020) PARP-1-regulated TNF-\u03b1 expression in the dorsal root ganglia and spinal dorsal horn contributes to the pathogenesis of neuropathic pain in rats. Brain Behav Immun 88:482\u2013496","DOI":"10.1016\/j.bbi.2020.04.019"},{"issue":"8","key":"3595_CR148","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.arcmed.2008.09.003","volume":"39","author":"D Huang","year":"2008","unstructured":"Huang D, Yang CZ, Yao L, Wang Y, Liao YH, Huang K (2008) Activation and overexpression of PARP-1 in circulating mononuclear cells promote TNF-\u03b1 and IL-6 expression in patients with unstable angina. Arch Med Res 39(8):775\u2013784","journal-title":"Arch Med Res"},{"issue":"24","key":"3595_CR149","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.2174\/092986709788803024","volume":"16","author":"E Esposito","year":"2009","unstructured":"Esposito E, Cuzzocrea S (2009) TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma. Curr Med Chem 16(24):3152\u20133167","journal-title":"Curr Med Chem"},{"issue":"2","key":"3595_CR150","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00018-013-1381-6","volume":"71","author":"J Sosna","year":"2014","unstructured":"Sosna J, Voigt S, Mathieu S et al (2014) TNF-induced necroptosis and PARP-1-mediated necrosis represent distinct routes to programmed necrotic cell death. Cell Mol Life Sci 71(2):331\u2013348","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"3595_CR151","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1210\/en.2009-1342","volume":"151","author":"VR Drel","year":"2010","unstructured":"Drel VR, Lupachyk S, Shevalye H et al (2010) New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-\u03b1. Endocrinology 151(6):2547\u20132555","journal-title":"Endocrinology"},{"issue":"1","key":"3595_CR152","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/sj.bjp.0706837","volume":"149","author":"M Haddad","year":"2006","unstructured":"Haddad M, Rhinn H, Bloquel C et al (2006) Anti-inflammatory effects of PJ34, a poly (ADP-ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice. Br J Pharmacol 149(1):23\u201330","journal-title":"Br J Pharmacol"},{"issue":"1","key":"3595_CR153","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-24350-x","volume":"8","author":"S Ismael","year":"2018","unstructured":"Ismael S, Zhao L, Nasoohi S, Ishrat T (2018) Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke. Sci Rep 8(1):1\u20139","journal-title":"Sci Rep"},{"issue":"1","key":"3595_CR154","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-016-0729-x","volume":"13","author":"S Rom","year":"2016","unstructured":"Rom S, Zuluaga-Ramirez V, Reichenbach NL et al (2016) PARP inhibition in leukocytes diminishes inflammation via effects on integrins\/cytoskeleton and protects the blood-brain barrier. J Neuroinflammation 13(1):1\u20136","journal-title":"J Neuroinflammation"},{"issue":"4","key":"3595_CR155","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.neuroscience.2010.10.029","volume":"171","author":"WB Haile","year":"2010","unstructured":"Haile WB, Echeverry R, Wu F, Guzman J, An J, Wu J, Yepes M (2010) Tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 mediate cerebral ischemia-induced poly (ADP-ribose) polymerase-1 activation and neuronal death. Neuroscience 171(4):1256\u20131264","journal-title":"Neuroscience"},{"issue":"6","key":"3595_CR156","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1002\/jcb.10569","volume":"89","author":"J W\u0119sierska-G\u0105dek","year":"2003","unstructured":"W\u0119sierska-G\u0105dek J, Wojciechowski J, Schmid G (2003) Phosphorylation regulates the interaction and complex formation between wt p53 protein and PARP-1. J Cell Biochem 89(6):1260\u20131348","journal-title":"J Cell Biochem"},{"key":"3595_CR157","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.biopha.2018.10.155","volume":"109","author":"A Gupta","year":"2019","unstructured":"Gupta A, Shah K, Oza MJ, Behl T (2019) Reactivation of p53 gene by MDM2 inhibitors: A novel therapy for cancer treatment. Biomed Pharmacother 109:484\u2013492","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"3595_CR158","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/bies.201300117","volume":"36","author":"R Elkholi","year":"2014","unstructured":"Elkholi R, Chipuk JE (2014) How do I kill thee? Let me count the ways: p53 regulates PARP-1 dependent necrosis. BioEssays 36(1):46\u201351","journal-title":"BioEssays"},{"issue":"7","key":"3595_CR159","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/sj.onc.1205169","volume":"21","author":"MT Valenzuela","year":"2002","unstructured":"Valenzuela MT, Guerrero R, N\u00fa\u00f1ez MI et al (2002) PARP-1 modifies the effectiveness of p53-mediated DNA damage response. Oncogene 21(7):1108\u20131116","journal-title":"Oncogene"},{"issue":"1","key":"3595_CR160","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12868-016-0333-0","volume":"18","author":"A Okuda","year":"2017","unstructured":"Okuda A, Kurokawa S, Takehashi M et al (2017) Poly (ADP-ribose) polymerase inhibitors activate the p53 signaling pathway in neural stem\/progenitor cells. BMC Neurosci 18(1):14","journal-title":"BMC Neurosci"},{"issue":"4","key":"3595_CR161","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1161\/STROKEAHA.111.680157","volume":"44","author":"RK Leak","year":"2013","unstructured":"Leak RK, Zhang L, Luo Y et al (2013) Peroxiredoxin 2 battles poly (ADP-ribose) polymerase 1-and p53-dependent prodeath pathways after ischemic injury. Stroke 44(4):1124\u20131134","journal-title":"Stroke"},{"key":"3595_CR162","doi-asserted-by":"crossref","unstructured":"Khan H, Tiwari P, Kaur A, Singh TG (2021) Sirtuin acetylation and deacetylation: a complex paradigm in neurodegenerative disease. Mol Neurobiol 58(8):3903\u20133917","DOI":"10.1007\/s12035-021-02387-w"},{"key":"3595_CR163","doi-asserted-by":"crossref","unstructured":"Kolthur-Seetharam U, Dantzer F, McBurney MW, Murcia GD, Sassone-Corsi P (2006) Control of AIF-mediated cell death by the functional interplay of SIRT1 and PARP-1 in response to DNA damage. Cell Cycle 5(8):873\u2013877","DOI":"10.4161\/cc.5.8.2690"},{"issue":"1","key":"3595_CR164","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4103\/2394-8108.162532","volume":"1","author":"KB Koronowski","year":"2015","unstructured":"Koronowski KB, Perez-Pinzon MA (2015) Sirt1 in cerebral ischemia. Brain Circ 1(1):69","journal-title":"Brain Circ"},{"key":"3595_CR165","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3389\/fnins.2018.00833","volume":"12","author":"JF Zhang","year":"2018","unstructured":"Zhang JF, Zhang YL, Wu YC (2018) The role of Sirt1 in ischemic stroke: pathogenesis and therapeutic strategies. Front Neurosci 12:833","journal-title":"Front Neurosci"},{"issue":"9","key":"3595_CR166","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1007\/s11064-016-1950-9","volume":"41","author":"H Deng","year":"2016","unstructured":"Deng H, Mi MT (2016) Resveratrol attenuates A\u03b2 25\u201335 caused neurotoxicity by inducing autophagy through the TYrRS-PARP1-SIRT1 signaling pathway. Neurochem Res 41(9):2367\u20132379","journal-title":"Neurochem Res"},{"issue":"11","key":"3595_CR167","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.3390\/biology10111097","volume":"10","author":"R Bandopadhyay","year":"2021","unstructured":"Bandopadhyay R, Singh T, Ghoneim MM, Alshehri S, Angelopoulou E, Paudel YN, Piperi C, Ahmad J, Alhakamy NA, Alfaleh MA, Mishra A (2021) Recent developments in diagnosis of epilepsy: scope of microRNA and technological advancements. Biology 10(11):1097","journal-title":"Biology"},{"issue":"6036","key":"3595_CR168","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1126\/science.1202723","volume":"332","author":"Z Mao","year":"2011","unstructured":"Mao Z, Hine C, Tian X et al (2011) SIRT6 promotes DNA repair under stress by activating PARP1. Science 332(6036):1443\u20131446","journal-title":"Science"},{"issue":"4","key":"3595_CR169","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.cmet.2011.03.004","volume":"13","author":"P Bai","year":"2011","unstructured":"Bai P, Cant\u00f3 C, Oudart H et al (2011) PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab 13(4):461\u2013468","journal-title":"Cell Metab"},{"key":"3595_CR170","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.arr.2017.10.001","volume":"40","author":"S Hekmatimoghaddam","year":"2017","unstructured":"Hekmatimoghaddam S, Firoozabadi AD, Zare-Khormizi MR, Pourrajab F (2017) Sirt1 and Parp1 as epigenome safeguards and microRNAs as SASP-associated signals, in cellular senescence and aging. Ageing Res Rev 40:120\u2013141","journal-title":"Ageing Res Rev"},{"issue":"11","key":"3595_CR171","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.tips.2007.08.005","volume":"28","author":"M Cohen-Armon","year":"2007","unstructured":"Cohen-Armon M (2007) PARP-1 activation in the ERK signaling pathway. Trends Pharmacol Sci 28(11):556\u2013560","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"3595_CR172","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.molcel.2006.12.012","volume":"25","author":"M Cohen-Armon","year":"2007","unstructured":"Cohen-Armon M, Visochek L, Rozensal D et al (2007) DNA-independent PARP-1 activation by phosphorylated ERK2 increases Elk1 activity: a link to histone acetylation. Mol Cell 25(2):297\u2013308","journal-title":"Mol Cell"},{"key":"3595_CR173","doi-asserted-by":"crossref","unstructured":"Liu L, Ke Y, Jiang X et al (2012) Lipopolysaccharide activates ERK\u2013PARP-1\u2013RelA pathway and promotes nuclear factor\u2013\u03baB transcription in murine macrophages Hum Immunol 73(5):439\u2013447","DOI":"10.1016\/j.humimm.2012.02.002"},{"issue":"11","key":"3595_CR174","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1007\/s10495-007-0127-z","volume":"12","author":"C Ethier","year":"2007","unstructured":"Ethier C, Labelle Y, Poirier GG (2007) PARP-1-induced cell death through inhibition of the MEK\/ERK pathway in MNNG-treated HeLa cells. Apoptosis 12(11):2037\u20132049","journal-title":"Apoptosis"},{"issue":"18","key":"3595_CR175","doi-asserted-by":"publisher","first-page":"7136","DOI":"10.1073\/pnas.0508606103","volume":"103","author":"TM Kauppinen","year":"2006","unstructured":"Kauppinen TM, Chan WY, Suh SW, Wiggins AK, Huang EJ, Swanson RA (2006) Direct phosphorylation and regulation of poly (ADP-ribose) polymerase-1 by extracellular signal-regulated kinases 1\/2. Proc Natl Acad Sci USA 103(18):7136\u20137141","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"3595_CR176","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep24950","volume":"6","author":"L Visochek","year":"2016","unstructured":"Visochek L, Grigoryan G, Kalal A et al (2016) A PARP1-ERK2 synergism is required for the induction of LTP. Sci Rep 6(1):1\u20136","journal-title":"Sci Rep"},{"issue":"3","key":"3595_CR177","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/glia.22441","volume":"61","author":"M Domercq","year":"2013","unstructured":"Domercq M, Mato S, Soria FN, S\u00e1nchez-g\u00f3mez MV, Alberdi E, Matute C (2013) Zn2+-induced ERK activation mediates PARP-1-dependent ischemic-reoxygenation damage to oligodendrocytes. Glia 61(3):383\u2013393","journal-title":"Glia"},{"issue":"2","key":"3595_CR178","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jss.2006.01.007","volume":"134","author":"F L\u00f3pez-Neblina","year":"2006","unstructured":"L\u00f3pez-Neblina F, Toledo-Pereyra LH (2006) Phosphoregulation of signal transduction pathways in ischemia and reperfusion. J Surg Res 134(2):292\u2013299","journal-title":"J Surg Res"},{"issue":"1","key":"3595_CR179","first-page":"17","volume":"1","author":"T Sugawara","year":"2004","unstructured":"Sugawara T, Fujimura M, Noshita N et al (2004) Neuronal death\/survival signaling pathways in cerebral ischemia. Neurochem Res 1(1):17\u201325","journal-title":"Neurochem Res"},{"issue":"3","key":"3595_CR180","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/08941930701366471","volume":"20","author":"CJ Mullonkal","year":"2007","unstructured":"Mullonkal CJ, Toledo-Pereyra LH (2007) Akt in ischemia and reperfusion. J Investig Surg 20(3):195\u2013203","journal-title":"J Investig Surg"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-022-03595-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-022-03595-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-022-03595-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T01:08:21Z","timestamp":1668301701000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-022-03595-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,18]]},"references-count":180,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["3595"],"URL":"https:\/\/doi.org\/10.1007\/s11064-022-03595-z","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,18]]},"assertion":[{"value":"21 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors read and given their consent for the final manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}